trending Market Intelligence /marketintelligence/en/news-insights/trending/l3Unk043-6Vzmh8Enr5Lrg2 content esgSubNav
In This List

Regenxbio appoints chief scientific officer

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Regenxbio appoints chief scientific officer

Regenxbio Inc. appointed Olivier Danos to the newly created position of chief scientific officer.

Danos will be reporting to Kenneth Mills, the company's president and CEO. Danos was most recently the senior vice president of cell and gene therapy at Biogen Inc.